Inotek Pharma (ITEK) Tops Q2 EPS by 7c
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Inotek Pharma (NASDAQ: ITEK) reported Q2 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- First Interstate BancSystem (FIBK) Tops Q3 EPS by 4c
- Berkshire Hills Bancorp (BHLB) Misses Q3 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!